unfortunately they cant make stuff up to make shareholders happy. Let's face it all the deals they have done appear to be with the wrong partners. Taking better deals than distributing through a major company and picking lesser known names for better margins. ITF Pharma (who had heard of them before the BV deal?) Aspen pretty useless. Ansell worse than useless. Mundi proof will be in pudding but not much see through yet. I agree management are stale and need a refresh with more distribution savvy members. This has been one of my most disappointing investments ever and I cut the lot post the second FDA BV failure, which was always put to shareholders as a no brainer it would be passed. Anyway I doubt anything will happen prior to the AGM - it never does. Good luck to you all but unlike AB after 15 years of nothing my patience ran out. I will continue to monitor progress just in case and happy to re enter on any sign of real commercialisation of anything! Best luck to you all.
SPL Price at posting:
$1.10 Sentiment: None Disclosure: Not Held
